Software

EvidentIQ Germany GmbH confirmed as a Platinum Pharma Supplier

EvidentIQ Germany was recognized as a Platinum Pharma Supplier by Qualifyze’s quality compliance program. This prestigious distinction acknowledges EvidentIQ Germany’s commitment to providing high-quality products and reliable services to the healthcare and pharmaceutical industries.

Receiving the Platinum Quality Compliance Certificate reflects EvidentIQ Germany’s dedication to excellence and reinforces its role as a trusted partner in advancing a healthier tomorrow. The recognition by Qualifyze demonstrates ’s consistent focus on quality and reliability, setting a standard in the pharmaceutical supply chain.

"We are immensely proud to receive the Platinum Pharma Supplier certification from Qualifyze. This recognition is a testament to our unwavering commitment to excellence in quality and reliability. At EvidentIQ, we strive to set the highest standards in the pharmaceutical supply chain, and this prestigious distinction reinforces our role as a trusted partner. We are particularly pleased that this audit report is easily accessible to all our clients for their qualification needs via the Qualifyze platform", says Rupert Sedlmayr, Quality Manager of the EvidentIQ Group.

Qualifyze’s overall scoring considers the following data:

  • Sites located in high-risk areas according to CAHRA indexes
  • Warning letters and non-compliance reports
  • Geographic diversification of site locations
  • Results of audits conducted by Qualifyze
  • Degree of regulatory compliance
  • Audited standards

About Qualifyze:

Since its launch in 2019, the Frankfurt-based company has been committed to supporting pharma companies with fast, flexible, and reliable supply chain compliance assessments.

With a global network of over 250 local expert auditors, 1,200+ pharma clients, and the world’s largest database of supplier compliance data from 2,000+ suppliers, Qualifyze has emerged as the leading provider of structured and analyzable GxP audit data resulting from onsite inspections in the pharmaceutical supply chain.

Learn more about Qualifyze: www.qualifyze.com

Learn more about Marvin: www.xclinical.com

Über die EvidentIQ Group GmbH

EvidentIQ is a leading provider of next-generation eClinical solutions designed for specialists in the clinical research market. Our comprehensive suite includes EDC, eCOA, ePRO, eTMF, and CTMS. All integrated within a single cloud platform to meet the evolving needs of clinical operations and data management. We combine our advanced eClinical suite with a robust data science portfolio, patient recruitment services, and real-world evidence solutions. EvidentIQ is committed to enhancing clinical trial results through innovative technology and expert support.

EvidentIQ supports 15 of the top 20 pharma companies through novel RWE solutions and 150+ SMB customers in over 20 countries, including US, Germany, France, UK, Italy, Japan and China.

Firmenkontakt und Herausgeber der Meldung:

EvidentIQ Group GmbH
Rathausmarkt 5
20095 Hamburg
Telefon: +49 (89) 4522775000
Telefax: +49 (89) 4522775900
https://evidentiq.com

Ansprechpartner:
Sabine Birkner
Marketing Manager
Telefon: +49 89 4522775-250
E-Mail: sabine.birkner@evidentiq.com
Für die oben stehende Story ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel